ST
NVS icon

Sabal Trust’s Novartis NVS Stock Holding History

Sabal Trust’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-3,325
Closed -$235K – 122
2016
Q3 		$235K Sell
3,325
-559
-14% -$40.7K 0.03% 116
2016
Q2 		$287K Sell
3,884
-1,914
-33% -$132K 0.03% 101
2016
Q1 		$377K Sell
5,798
-3,682
-39% -$250K 0.04% 89
2015
Q4 		$731K Sell
9,480
-250,098
-96% -$19.9M 0.1% 61
2015
Q3 		$21.4M Sell
259,578
-10,050
-4% -$894K 2.99% 9
2015
Q2 		$23.8M Sell
269,628
-926
-0.3% -$85K 3.09% 4
2015
Q1 		$23.9M Buy
270,554
+240
+0.1% +$21.3K 3.14% 4
2014
Q4 		$22.4M Sell
270,314
-2,640
-1% -$219K 2.91% 8
2014
Q3 		$23M Sell
272,954
-1,338
-0.5% -$108K 3.09% 9
2014
Q2 		$22.3M Buy
274,292
+2,331
+0.9% +$183K 3.17% 7
2014
Q1 		$20.7M Sell
271,961
-4,881
-2% -$356K 2.93% 9
2013
Q4 		$19.9M Buy
276,842
+5,955
+2% +$414K 2.84% 10
2013
Q3 		$18.6M Buy
270,887
+5,289
+2% +$350K 2.9% 9
2013
Q2 		$16.8M Buy
+265,598
New +$17.3M 2.69% 11

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

Sabal Trust's NVS Position: Q4 2016 in Review

Sabal Trust sold out of Novartis (NVS) in Q4 2016, closing a stake of 3,325 shares — an estimated $235K sold.

Sabal Trust first reported a position in NVS in Q2 2013 and held it in 14 quarters. The position peaked at $23.9M in Q1 2015. 904 funds tracked by Wall St. Rank hold NVS as of Q4 2016.

  • Sabal Trust reported no remaining Novartis position as of Q4 2016 after selling out during the quarter.
  • Sabal Trust sold 3,325 Novartis shares in Q4 2016, an estimated $235K.
  • Sabal Trust first reported a position in Novartis in Q2 2013 and held it in 14 quarters.
  • Sabal Trust's Novartis position peaked at $23.9M in Q1 2015.
  • 904 funds tracked by Wall St. Rank held Novartis as of Q4 2016.

Based on Sabal Trust's 13F filing for Q4 2016, filed 18 Jan 2017.